Nandan most recently served as Senior Vice President, Innovation, at the Joslin Diabetes Center where he led an initiative to build alliances with pharma, biotech, and device/digital health companies across all areas of diabetes. Prior to Joslin, Nandan was founder and CEO of Nuvera Biosciences, a cancer diagnostics spinout of MD Anderson, and Silico Insights, a bioinformatics company providing drug discovery analytics to pharma and biotech. Nandan joined Altus Biologics, a startup in Boston focused on developing crystalline enzymes as therapeutics. He serves as an advisor to several biotech companies and entrepreneurs within the Boston area.
Dr. Padukone holds an M.B.A. from University of Denver, a Ph.D. in Biochemical Engineering from NC State University, an M.S. in Chemical Engineering from SUNY Buffalo, and a B.Tech. in Chemical Engineering from IIT, Mumbai.